Pharmacokinetic Study of (S)‐(−)‐2‐(N‐Propyl‐N‐(2‐thienylethyl)amino)‐5‐hydroxytetralin Infusion in Cynomolgus Monkeys
- 1 May 1994
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 83 (5) , 758-760
- https://doi.org/10.1002/jps.2600830533
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of the Dopamine D2 Agonist S(-)-2-(M-Propyl-M-2-thienylethylamino)-5-hydroxytetralin in Freely Moving RatsJournal of Pharmaceutical Sciences, 1993
- Reversed-phase liquid chromatographic method with amperometric detection for the determination of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1990
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolitesXenobiotica, 1990
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration I. Disposition and metabolic profilingXenobiotica, 1990
- Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437European Journal of Pharmacology, 1989
- The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamineEuropean Journal of Pharmacology, 1989
- The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptorsEuropean Journal of Pharmacology, 1988
- N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonistsEuropean Journal of Pharmacology, 1984